• Published

  June 20, 2021
  

  Controversial new Alzheimer’s drug gives patients in Maine hope

  The treatment developed by Biogen could slow its progression, but health professionals and researchers are divided on whether the FDA was right to approve it.

• Published

  December 17, 2020
  

  Maine delegation united on bill to help veterans with early-stage dementia

  The measure, which is on its way to President Trump to be signed into law, would relax eligibility rules that have stopped some veterans from receiving care at state-run veterans homes.